about
The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillanceATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear ForceAlternative functions of the brain transsulfuration pathway represent an underappreciated aspect of brain redox biochemistry with significant potential for therapeutic engagementRole of glucose metabolism and ATP in maintaining PINK1 levels during Parkin-mediated mitochondrial damage responses.Increased Sensitivity to Noise-Induced Hearing Loss by Blockade of Endogenous PI3K/Akt Signaling.Pten regulates homeostasis and inflammation-induced migration of myelocytes in zebrafishPemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway.miR-155 Controls Lymphoproliferation in LAT Mutant Mice by Restraining T-Cell Apoptosis via SHIP-1/mTOR and PAK1/FOXO3/BIM PathwaysMild hypoxia in vivo regulates cardioprotective SUR2A: A role for Akt and LDH.Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors.Placental phenotype and resource allocation to fetal growth are modified by the timing and degree of hypoxia during mouse pregnancy.Inhibition of glycogen synthase kinase 3β activity with lithium prevents and attenuates paclitaxel-induced neuropathic pain.mTOR has distinct functions in generating versus sustaining humoral immunity.Targeting GRP75 improves HSP90 inhibitor efficacy by enhancing p53-mediated apoptosis in hepatocellular carcinoma.Kinase inhibitors as potential agents in the treatment of multiple myeloma.Targeting PI3K/mTOR Signaling in Cancer.The Pasteur's Dictum: Nitrogen Promotes Growth and Oxygen Reduces the Need for Sugar.The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism.AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate.Mitochondrial cyclophilin D ablation is associated with the activation of Akt/p70S6K pathway in the mouse kidney.Diamond, graphite, and graphene oxide nanoparticles decrease migration and invasiveness in glioblastoma cell lines by impairing extracellular adhesionDid we get pasteur, warburg, and crabtree on a right note?Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.The Arf-GAP and protein scaffold Cat1/Git1 as a multifaceted regulator of cancer progression.Exploiting radiation-induced signaling to increase the susceptibility of resistant cancer cells to targeted drugs: AKT and mTOR inhibitors as an example.Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.Importance of phosphoinositide binding by human β-defensin 3 for Akt-dependent cytokine induction.Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.The role of mTOR-mediated signals during haemopoiesis and lineage commitment
P2860
Q26739246-F0AD2651-D83B-471F-B76A-95A9D6C54889Q26744723-F87512DC-1BC4-4F0E-B538-709067F4D94AQ26851534-C66D5206-405C-44BC-87AF-B2EA393A2678Q27314571-8141FDA7-C6BC-434C-9E3E-C77D77443681Q30382377-A1DEE0F6-DDF1-4AB0-8001-FA6A7FE6F062Q30577765-0E1797D7-9D01-4110-82FD-177DF5A5B798Q33646091-81F04B26-CF64-4F2F-9965-B7FEE1C654D7Q35676981-A2D5E12A-F409-4D4B-91B1-92ADE5B12C1AQ35989366-144B5501-DF16-45D2-B2FB-DAA1690D5247Q36543877-626E9593-D376-45E2-812A-48ADDB96F2F7Q36632607-6564598C-069F-4227-A160-A7FDC28AA61EQ37317816-9A0A25CC-7C63-408F-A2D7-9A69E29ED0E7Q37395797-5233CA0B-67CE-4630-985B-AE7A484173E3Q37490724-E660220A-E493-49E4-A991-4813B8AA80B1Q37697253-2296A73A-4220-4678-BC66-1205FC208620Q37725655-93714492-EE61-4DBF-A0B8-992CA5EEA0B7Q38199693-01B5EB88-E5F8-4341-94CD-B80E4718786FQ38635458-EB7FEE45-A6D8-4ADF-B0C0-5256054592AEQ40154948-8EA3F8AF-58CB-4104-B146-3D8EFB8E467CQ41520294-50080604-B4E0-41D5-98C5-8606026857E9Q41621256-B95734C3-4852-468F-8CB8-D1175EA9B61AQ42373821-D816FEAB-04BE-40B4-AB4B-CD54A53DD30BQ43092602-FE2DBF2A-5ECA-414B-9FA7-F13E07232EF5Q44551180-CDEA39A1-507D-4689-8BC1-2BEF39C744EFQ47693046-515D8B15-57CE-4B17-AE97-3D3D7A6848D8Q47960830-3E488FB0-B00D-446E-9F65-CD9D36D09A96Q48011517-1F27219F-6F23-4D2E-91FF-97E2E664BE9DQ49852449-D9EB20F4-37EC-4F20-BC91-DC5380D3B334Q52586939-84FD9521-BB5A-49AE-8205-1E3B882B7BD4Q54979733-58DAD0FC-10B6-454D-9387-B2FF37367E7AQ58696922-F8420377-6AC3-4AE8-9AFB-893F9EE0FFED
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The Paradox of Akt-mTOR Interactions.
@en
type
label
The Paradox of Akt-mTOR Interactions.
@en
prefLabel
The Paradox of Akt-mTOR Interactions.
@en
P2093
P2860
P356
P1476
The Paradox of Akt-mTOR Interactions
@en
P2093
Abhinandita Dash
Kotha Anil Kumar
Mukesh Pasupuleti
Pallu Reddanna
P2860
P356
10.3389/FONC.2013.00165
P577
2013-06-20T00:00:00Z